{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Amid rising concern about the cost of prescription drugs, Vermont is expected today to become the first state in the nation to require pharmaceutical companies to disclose their gifts and cash payments to doctors, hospitals and other health care providers. ''Drug companies are giving doctors free dinners and flying them to Florida for a vacation,'' said Vermont's governor, Howard Dean, a Democrat. He plans to sign the disclosure bill, which has been passed by both houses of the Legislature, in Montpelier, the state capital, today.", "headline": {"main": "Vermont to Require Drug Makers To Disclose Payments to Doctors"}, "abstract": "Vermont, amid rising concern about cost of prescription drugs, is expected to become first state in nation to require pharmaceutical companies to disclose their gifts and cash payments to doctors, hospitals and other health care providers; Vermont Gov Howard Dean says drug companies are giving doctors free dinners and flying them to Flordia for vacation; Dean plans to sign disclosure bill; adds such gifts could influence physicians to prescribe certain drugs, often most expensive ones; Vermont legislation is part of growing effort by state and federal lawmakers to rein in drug companies' marketing practices; chart lists some bills that have been or are being considered in other states; photo (M)", "print_page": "1", "word_count": 1086, "_id": "4fd21cf88eb7c8105d79d693", "snippet": "Amid rising concern about the cost of prescription drugs, Vermont is expected today to become the first state in the nation to require pharmaceutical companies to disclose their gifts and cash payments to doctors, hospitals and other health care...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/13/business/vermont-to-require-drug-makers-to-disclose-payments-to-doctors.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "DEAN, HOWARD"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "glocations", "value": "ILLINOIS"}, {"name": "glocations", "value": "CONNECTICUT"}, {"name": "glocations", "value": "KENTUCKY"}, {"name": "glocations", "value": "MAINE"}, {"name": "glocations", "value": "CALIFORNIA"}, {"name": "glocations", "value": "HAWAII"}, {"name": "glocations", "value": "VERMONT"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "ETHICS"}, {"name": "subject", "value": "GIFTS"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "HOSPITALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-06-13T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "A study being released today has found that about half of a group of people with chronic asthma also suffered from low-level lung infections, and that antibiotic treatment improved their breathing. In recent years, many researchers have been investigating whether bacterial infections play a role in causing or worsening the lung inflammation that produces asthma.", "headline": {"main": "Easing Asthmatics' Congestion", "kicker": "VITAL SIGNS: CAUSE AND EFFECT"}, "abstract": "National Jewish Medical and Research Center, in study published in journal Chest, finds that about half of study group of 55 people with chronic asthma also suffered from low-level lung infections and that antibiotic treatment improves breathing (M)", "print_page": "7", "word_count": 258, "_id": "4fd26a528eb7c8105d821aee", "snippet": "A study being released today has found that about half of a group of people with chronic asthma also suffered from low-level lung infections, and that antibiotic treatment improved their breathing.     In recent years, many researchers have been...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/11/health/vital-signs-cause-and-effect-easing-asthmatics-congestion.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "NATIONAL JEWISH MEDICAL AND RESEARCH CENTER"}, {"name": "subject", "value": "INFECTIONS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "ASTHMA"}, {"name": "subject", "value": "ANTIBIOTICS"}, {"name": "subject", "value": "LUNGS"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "John", "lastname": "O'Neil"}], "original": "By John O'Neil"}, "document_type": "article", "pub_date": "2002-06-11T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Medical journals are the prime source of information about scientific advances that can change how doctors treat patients in offices and in hospitals. And to ensure the quality of what journals publish, their editors, beginning 200 years ago, have increasingly called on scientific peers to review new findings from research in test tubes and on animals and humans. The system, known as peer review, is now considered a linchpin of science. Editors of the journals and many scientists consider the system's expense and time consumption worthwhile in the belief that it weeds out shoddy work and methodological errors and blunts possible biases by scientific investigators. Another main aim is to prevent authors from making claims that cannot be supported by the evidence they report.", "headline": {"main": "When Peer Review Produces Unsound Science", "kicker": "THE DOCTOR'S WORLD"}, "abstract": "Article on problems within scientific peer review system; Journal of American Medical Assn, after fourth meeting on research on peer review since 1989, reports considerable evidence that many statistical and methodological errors are common in published papers and that authors often fail to discuss limitations of their findings; journal editor Dr Drummond Rennie says that despite improvements, there is still massive amount of 'rubbish' published in medical journals; photo (M)", "print_page": "6", "word_count": 1325, "_id": "4fd2362e8eb7c8105d7c8197", "snippet": "Medical journals are the prime source of information about scientific advances that can change how doctors treat patients in offices and in hospitals. And to ensure the quality of what journals publish, their editors, beginning 200 years ago, have...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/11/health/the-doctor-s-world-when-peer-review-produces-unsound-science.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "RENNIE, DRUMMOND"}, {"name": "organizations", "value": "JOURNAL OF THE AMERICAN MEDICAL ASSN"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN, M.D"}, "document_type": "article", "pub_date": "2002-06-11T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The Food and Drug Administration said yesterday that Celebrex, a top-selling arthritis drug, must continue to carry a warning on its label that it can cause serious ulcer complications just as many other pain relievers can. But in a potential boost to Celebrex, which is in a heated marketing battle with Vioxx, the F.D.A. said the risk of heart attacks among patients taking Celebrex was no higher than for those taking two generic pain medications. Earlier this year, the F.D.A. required that a precaution be added to Vioxx's label about the potential risk of heart attacks.", "headline": {"main": "F.D.A. Takes Mixed Stance On a Leading Arthritis Drug"}, "abstract": "Food and Drug Administration says that Celebrex, a top-selling arthritis drug, must continue to carry warning on its label that it can cause serious ulcer complications just as many other pain relievers can; but in potential boost to Celebrex, which is in heated marketing battle with Vioxx, FDA says risk of heart attacks among patients taking Celebrex is no higher than for those taking two generic pain medications (M)", "print_page": "2", "word_count": 689, "_id": "4fd21ac78eb7c8105d79991e", "snippet": "The Food and Drug Administration said yesterday that Celebrex, a top-selling arthritis drug, must continue to carry a warning on its label that it can cause serious ulcer complications just as many other pain relievers can.    But in a potential...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/08/business/fda-takes-mixed-stance-on-a-leading-arthritis-drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "CELEBREX (DRUG)"}, {"name": "subject", "value": "ULCERS"}, {"name": "subject", "value": "ARTHRITIS"}, {"name": "subject", "value": "PAIN-RELIEVING DRUGS"}, {"name": "subject", "value": "VIOXX (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-06-08T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 4, "offset": 0, "time": 40}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}